Terms: = Prostate cancer AND PIK3R1, P27986, 5295, ENSG00000145675, p85-ALPHA, GRB1
16 results:
1. Network pharmacology and molecular docking to explore the mechanism of Sheng Xue Bao mixture against iron deficiency anemia.
Wang Y; Qinqin H; Wang H; Zhang H; Zhang X; Liu W; Xiang Z; Gu Y
Medicine (Baltimore); 2023 Sep; 102(37):e35012. PubMed ID: 37713882
[TBL] [Abstract] [Full Text] [Related]
2. A comprehensive comparison between mpMRI of the prostate, MR-US fusion biopsy and whole mount histopathology.
Doblhammer S; Kinger P; Starmuehler M; Muschitz C; Schima W; Susani M; Baierl A; Broessner C
World J Urol; 2023 Apr; 41(4):1055-1060. PubMed ID: 36840753
[TBL] [Abstract] [Full Text] [Related]
3. The Impact of pik3r1 Mutations and Insulin-PI3K-Glycolytic Pathway Regulation in prostate cancer.
Chakraborty G; Nandakumar S; Hirani R; Nguyen B; Stopsack KH; Kreitzer C; Rajanala SH; Ghale R; Mazzu YZ; Pillarsetty NVK; Lee GM; Scher HI; Morris MJ; Traina T; Razavi P; Abida W; Durack JC; Solomon SB; Vander Heiden MG; Mucci LA; Wibmer AG; Schultz N; Kantoff PW
Clin Cancer Res; 2022 Aug; 28(16):3603-3617. PubMed ID: 35670774
[TBL] [Abstract] [Full Text] [Related]
4. miR-221 Augments TRAIL-Mediated Apoptosis in prostate cancer Cells by Inducing Endogenous TRAIL Expression and Targeting the Functional Repressors SOCS3 and pik3r1.
Krebs M; Behrmann C; Kalogirou C; Sokolakis I; Kneitz S; Kruithof-de Julio M; Zoni E; Rech A; Schilling B; Kübler H; Spahn M; Kneitz B
Biomed Res Int; 2019; 2019():6392748. PubMed ID: 31828111
[TBL] [Abstract] [Full Text] [Related]
5. Integrative Exome Sequencing Analysis in Castration-Resistant prostate cancer in Chinese Population.
Hao L; Li H; Zhang S; Yang Y; Xu Z; Zhang Y; Liu Z
Curr Pharm Biotechnol; 2020; 21(2):140-148. PubMed ID: 31580249
[TBL] [Abstract] [Full Text] [Related]
6. Identification of Potential miRNAs Biomarkers for High-Grade prostate cancer by Integrated Bioinformatics Analysis.
Foj L; Filella X
Pathol Oncol Res; 2019 Oct; 25(4):1445-1456. PubMed ID: 30367364
[TBL] [Abstract] [Full Text] [Related]
7. Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancer.
Ye Y; Li SL; Wang SY
PLoS One; 2018; 13(8):e0198055. PubMed ID: 30138363
[TBL] [Abstract] [Full Text] [Related]
8. Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in prostate cancer.
Wyatt AW; Annala M; Aggarwal R; Beja K; Feng F; Youngren J; Foye A; Lloyd P; Nykter M; Beer TM; Alumkal JJ; Thomas GV; Reiter RE; Rettig MB; Evans CP; Gao AC; Chi KN; Small EJ; Gleave ME
J Natl Cancer Inst; 2017 Dec; 109(12):. PubMed ID: 29206995
[TBL] [Abstract] [Full Text] [Related]
9. Organoid cultures derived from patients with advanced prostate cancer.
Gao D; Vela I; Sboner A; Iaquinta PJ; Karthaus WR; Gopalan A; Dowling C; Wanjala JN; Undvall EA; Arora VK; Wongvipat J; Kossai M; Ramazanoglu S; Barboza LP; Di W; Cao Z; Zhang QF; Sirota I; Ran L; MacDonald TY; Beltran H; Mosquera JM; Touijer KA; Scardino PT; Laudone VP; Curtis KR; Rathkopf DE; Morris MJ; Danila DC; Slovin SF; Solomon SB; Eastham JA; Chi P; Carver B; Rubin MA; Scher HI; Clevers H; Sawyers CL; Chen Y
Cell; 2014 Sep; 159(1):176-187. PubMed ID: 25201530
[TBL] [Abstract] [Full Text] [Related]
10. Four microRNAs promote prostate cell proliferation with regulation of PTEN and its downstream signals in vitro.
Tian L; Fang YX; Xue JL; Chen JZ
PLoS One; 2013; 8(9):e75885. PubMed ID: 24098737
[TBL] [Abstract] [Full Text] [Related]
11. Various effects of hepatoma-derived growth factor on cell growth, migration and invasion of breast cancer and prostate cancer cells.
Guo Z; He Y; Wang S; Zhang A; Zhao P; Gao C; Cao B
Oncol Rep; 2011 Aug; 26(2):511-7. PubMed ID: 21567096
[TBL] [Abstract] [Full Text] [Related]
12. Genetic polymorphisms in inflammation pathway genes and prostate cancer risk.
Kwon EM; Salinas CA; Kolb S; Fu R; Feng Z; Stanford JL; Ostrander EA
Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):923-33. PubMed ID: 21430300
[TBL] [Abstract] [Full Text] [Related]
13. The phosphoinositide 3-kinase regulatory subunit p85alpha can exert tumor suppressor properties through negative regulation of growth factor signaling.
Taniguchi CM; Winnay J; Kondo T; Bronson RT; Guimaraes AR; Alemán JO; Luo J; Stephanopoulos G; Weissleder R; Cantley LC; Kahn CR
Cancer Res; 2010 Jul; 70(13):5305-15. PubMed ID: 20530665
[TBL] [Abstract] [Full Text] [Related]
14. E17K substitution in AKT1 in prostate cancer.
Boormans JL; Korsten H; Ziel-van der Made AC; van Leenders GJ; Verhagen PC; Trapman J
Br J Cancer; 2010 May; 102(10):1491-4. PubMed ID: 20407443
[TBL] [Abstract] [Full Text] [Related]
15. A comprehensive analysis of transcript signatures of the phosphatidylinositol-3 kinase/protein kinase B signal-transduction pathway in prostate cancer.
Hellwinkel OJ; Rogmann JP; Asong LE; Luebke AM; Eichelberg C; Ahyai S; Isbarn H; Graefen M; Huland H; Schlomm T
BJU Int; 2008 Jun; 101(11):1454-60. PubMed ID: 18336616
[TBL] [Abstract] [Full Text] [Related]
16. Prognostic value of the Gleason score in prostate cancer.
Egevad L; Granfors T; Karlberg L; Bergh A; Stattin P
BJU Int; 2002 Apr; 89(6):538-42. PubMed ID: 11942960
[TBL] [Abstract] [Full Text] [Related]
